Cargando…

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome

BACKGROUND: Trisomy 21 causes Down syndrome (DS) and is a recognized cause of early-onset Alzheimer’s disease (AD). OBJECTIVE: The current study sought to determine if premorbid intellectual disability level (ID) was associated with variability in age-trajectories of AD biomarkers and cognitive impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartley, Sigan L., Fleming, Victoria, Schworer, Emily K., Peven, Jamie, Handen, Benjamin L., Krinsky-McHale, Sharon, Hom, Christy, Lee, Laisze, Tudorascu, Dana L., Laymon, Charles, Minhas, Davneet, Luo, Weiquan, Cohen, Annie, Zaman, Shahid, Ances, Beau M., Mapstone, Mark, Head, Elizabeth, Lai, Florence, Rosas, H. Diana, Klunk, William, Christian, Bradley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578224/ https://www.ncbi.nlm.nih.gov/pubmed/37482997 http://dx.doi.org/10.3233/JAD-230200

Ejemplares similares

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging
por: Laymon, Charles M., et al.
Publicado: (2021)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

White matter microstructure associations to amyloid burden in adults with Down syndrome
por: Bazydlo, Austin M., et al.
Publicado: (2021)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application
por: Minhas, Davneet S., et al.
Publicado: (2020)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
por: Minhas, Davneet S., et al.
Publicado: (2018)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

A multi-scanner neuroimaging data harmonization using RAVEL and ComBat
por: Torbati, Mahbaneh Eshaghzadeh, et al.
Publicado: (2021)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

MISPEL: A supervised deep learning harmonization method for multi-scanner neuroimaging data
por: Torbati, Mahbaneh Eshaghzadeh, et al.
Publicado: (2023)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Alzheimer's risk and quality of life: History of Down syndrome as a case in point
por: Silverman, Wayne, et al.
Publicado: (2021)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Sleep and White Matter in Adults with Down Syndrome
por: Fleming, Victoria, et al.
Publicado: (2021)

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017)

Persistent trophoblastic atypia on endocervical curettage found to be an epithelioid trophoblastic Tumor: A case report and review of the literature
por: Brodsky, Allison L., et al.
Publicado: (2022)

Maturation of the human striatal dopamine system revealed by PET and quantitative MRI
por: Larsen, Bart, et al.
Publicado: (2020)

Ophthalmic Disorders in Adults with Down Syndrome
por: Krinsky-McHale, Sharon J., et al.
Publicado: (2012)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

An improved method for detecting telomere size differences in T-lymphocyte interphases from older people with Down syndrome with and without mild cognitive impairment
por: Jenkins, E. C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lhjpj3v2ejk4ln6gvdtt33rc94